高级检索
当前位置: 首页 > 详情页

Calcium channel TRPV6 promotes breast cancer metastasis by NFATC2IP

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Shanghai Jiao Tong Univ, Tongren Hosp, Basic Med Inst,Minist Educ, Hongqiao Int Inst Med,Sch Med,Key Lab Cell Differ, Shanghai 200025, Peoples R China [2]Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Lab Med, Jiading Branch,Sch Med, Shanghai, Peoples R China [3]Shanghai Jiao Tong Univ, Tongren Hosp, Dept Gastroenterol, Sch Med, Shanghai 200025, Peoples R China [4]Shandong Univ, Shandong Acad Med Sci, Dept Radiat Oncol, Shandong Canc Hosp, Jinan 250117, Shandong, Peoples R China [6]Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
出处:
ISSN:

关键词: Breast cancer NFATC2IP CDK5 Metastasis TRPV6

摘要:
Calcium channel TRPV6 upregulation is associated with poor prognosis of breast cancer by promoting invasion and metastasis, and TRPV6 is a potential target for breast cancer therapy. However, the mechanism by which TRPV6 promotes breast metastasis remains unclear. Here, we report that TRPV6 expression is upregulated in metastatic breast cancers and that TRPV6 overexpression or upregulation accelerates primary breast cancer cell migration. In contrast, TRPV6 suppression decreases cell migration. Mechanistically, TRPV6 activates NFATC2 by increasing NFATC2IP phosphorylation at Ser204, and CDK5 is a candidate kinase that may perform this phosphorylation. Consequently, activated NFATC2 increases breast cancer metastasis by upregulating ADAMTS6 expression. These observations suggest that TRPV6 increases NFATC2 transcriptional activity by increasing NFATC2IP phosphorylation, which consequently upregulates ADAMTS6 expression to promote breast cancer metastasis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学
最新[2023]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Shanghai Jiao Tong Univ, Tongren Hosp, Basic Med Inst,Minist Educ, Hongqiao Int Inst Med,Sch Med,Key Lab Cell Differ, Shanghai 200025, Peoples R China [2]Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Lab Med, Jiading Branch,Sch Med, Shanghai, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Shanghai Jiao Tong Univ, Tongren Hosp, Basic Med Inst,Minist Educ, Hongqiao Int Inst Med,Sch Med,Key Lab Cell Differ, Shanghai 200025, Peoples R China [2]Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Lab Med, Jiading Branch,Sch Med, Shanghai, Peoples R China [4]Shandong Univ, Shandong Acad Med Sci, Dept Radiat Oncol, Shandong Canc Hosp, Jinan 250117, Shandong, Peoples R China [*1]Department of Biochemistry and Molecular Cell Biology [*2]Department of Radiation Oncology, Shandong Cancer Hospital affiliated to Shandong University, Shandong Academy of Medical Sciences, Jinan, Shandong, 250117, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)